ADMA

ADMA Operating Cash Flow Growth

78.23%TTM

Period ending:

ADMA TTM Cash from Operations YoY %%
ADMA TTM Cash from Operations YoY %4185.25%-26159.43%
2008-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

ADMA operating cash flow growth history

Year-over-year operating cash flow growth rate. The available trailing twelve months (ttm) series contains 70 observations from Dec 31, 2008 to Jun 30, 2026.

Adma Biologics Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
78.2343%
26.7796%
-57.5334%
-24.4956%
5.0666%
375.0942%
1,248.6687%
631.9707%
276.1551%
144.1832%
114.7865%
81.1014%
51.6508%
54.1452%
47.0421%
22.9736%
29.4836%
4.9119%
-10.1625%
-24.2494%
-36.2602%
-27.7654%
-33.8736%
-18.7178%
-38.8592%
-42.9882%
-21.5621%
-31.6022%
-18.0152%
-25.3052%
-68.1666%
-107.9578%
-142.2724%
-161.1289%
-104.0168%
-46.939%
-34.3667%
-13.039%
-18.4881%
-31.5312%
-19.151%
-17.862%
-4.8521%
3.5199%
3.3507%
-8.0344%
-35.0666%
-51.6496%
-51.1143%
-61.0643%
-57.6981%
-90.5137%
-218.8898%
-294.1859%
-23,222.8438%
-19,712.2334%
-10,291.6207%
-8,610.0594%
-27.349%
99.6944%
99.7906%
99.8728%
99.8975%
22.3673%
-47.7158%
-154.6405%
-158.5955%
50.6656%
58.0321%
49.136%

Compare operating cash flow growth

All ADMA financial metrics · ADMA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.